Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2026)

Cytek Biosciences has reported Other Working Capital Changes for 7 years, with the latest figure at -$3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 272.27% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at $783000.0 (up 451.12% YoY), and the FY2025 full-year result was $3.6 million, down 3.64% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$3.9 million, down from $1.7 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $8.6 million in Q3 2023, with the low at -$3.9 million in Q1 2026.
• Historically, Other Working Capital Changes has averaged $1.3 million across 5 years, with a median of $1.7 million in 2025.
• Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 6069.39% — and 2026, when it tumbled 272.27%.
• Cytek Biosciences' Other Working Capital Changes stood at $2.9 million in 2022, then dropped by 21.13% to $2.3 million in 2023, then soared by 162.59% to $6.0 million in 2024, then sank by 71.24% to $1.7 million in 2025, then sank by 321.95% to -$3.9 million in 2026.
• The last three Other Working Capital Changes figures came in at -$3.9 million (Q1 2026), $1.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.